This article is part of the supplement: 35te Tagung der Pathologen am Oberrhein/35th Meeting of Pathologists of the Upper Rhine Region (PATOR)Diagnosis of Burkitt's lymphoma in due time: a practical approach1Department of Pathology, Kantonsspital, St. Gallen, Switzerland 2Institute for Cancer Genetics, Columbia University, New York, NY, USA 3Department of Internal Medicine, Kantonsspital, St. Gallen, Switzerland 4Department of Pathology, University Hospital, Ulm, Germany
from 35te Tagung der Pathologen am Oberrhein/35th Meeting of Pathologists of the Upper Rhine Region (PATOR) Diagnostic Pathology 2007, 2(Suppl 1):S6doi:10.1186/1746-1596-2-S1-S6
First paragraph (this article has no abstract)The quick diagnosis of Burkitt's lymphoma (BL) and its clear-cut differentiation from diffuse large B-cell lymphoma (DLBCL) is of great clinical importance since treatment for these two disease entities differ markedly and should promptly be initiated in BL. However, these two tumours are difficult to distinguish using the current WHO classification, particularly in regard to BL variants, i.e., BL with plasmacytoid differentiation and atypical Burkitt's/Burkitt's-like lymphomas. |




on Google Scholar





corresponding author email